The Latest

COVID-19 mask

Is HIV Itself a Marker for Worse COVID-19 Outcomes? Research Remains Mixed

Over a year into the COVID-19 pandemic, clinicians’ worst fears about HIV and COVID-19 don’t appear to have materialized—but there remains a lot of uncertainty.

By Larry Buhl
doctor talking to senior patient

Older Adults Living With HIV Often Have Delayed Entry Into Care

A new study shows that almost two-thirds of older adults who were diagnosed with HIV at a Connecticut clinic were already at an advanced stage of disease progression.

By Michael Broder
human heart

Recent Research Highlights Difficulty in Measuring Heart Disease Risk for People Living With HIV

Two studies out of Europe aimed to give data on which patients with HIV benefit most from lipid-lowering medications, but they both ultimately concluded that better CVD risk-assessment tools—targeted specifically for PLWH—are needed.

By Larry Buhl
magnifying glass

This Week in HIV Research: The Importance of Challenging Our Assumptions

Feb. 25, 2021: High HCV SVR among people using substances; geographic HIV care disparities among Black Americans; self-administered imiquimod vs. ASIL excision; PrEP uptake in syringe service programs.

By Barbara Jungwirth and Myles Helfand
Stephaun Wallace, Ph.D., M.S., and Raniyah Copeland

“It’s About Our Community”: Newly Formed Science Initiative Aims to Center the Black Experience in HIV and COVID Care

Raniyah Copeland and Stephaun Wallace explain the mission and context for the Black AIDS Institute’s new Scientific Advisory Committee.

By Terri Wilder, M.S.W.
stop virus

Injectable Long-Acting PrEP Is Safe, Highly Effective in Cisgender Women

The findings add to evidence that injectable PrEP could ultimately have greater real-world efficacy than daily oral PrEP in many populations, thanks to better adherence.

By Michael Broder
good sleep

This Week in HIV Research: To Sleep, Perchance to Dream

Feb. 18, 2021: Insomnia rates among PLWH; trends in multimorbidity diagnosis; viral load control loss in the modern HIV treatment era; acceptability of HIV self-test dissemination methods.

By Barbara Jungwirth and Myles Helfand
rapid HIV test

This Week in HIV Research: Early Screening Matters, and Not Just for HIV

Feb. 11, 2021: Early comorbidity development among women living with HIV; type 2 heart attack frequency; assessing European-based CVD assessment tools; long-term cognitive dysfunction and HIV/hepatitis coinfection.

By Barbara Jungwirth and Myles Helfand
genetic analysis

The Future of HIV Treatment and Prevention Is Coming, and It’s Spelled bNAb

New findings from the Antibody-Mediated Prevention (AMP) studies indicate that broadly neutralizing antibodies can work, but several will need to be used in combination.

By Michael Broder

This Week in HIV Research: What Risk Compensation?

Feb. 4, 2021: STI rates among PrEP users; how Medicaid expansion affects HIV testing and PrEP rates; utilizing mental health care providers in PrEP uptake; adapting HIV care in the COVID era.

By Barbara Jungwirth and Myles Helfand